Cohance Lifesciences Limited has informed the Exchange about Copy of Newspaper Publication
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cohance Lifesciences (formerly Suven Pharmaceuticals) has published a notice to its shareholders in Business Standard (English) and Navshakti (Marathi) newspapers on September 24, 2025, as part of SEBI's 'Saksham Niveshak' (Empowered Investor) campaign. The 100-day campaign, running from July 28, 2025 to October 6, 2025, is aimed at helping shareholders claim unpaid dividends and update their KYC details. The notice has also been hosted on the company's website (suvenpharm.com/advertisements). Shareholders can use the dedicated KYC and claim forms made available through the company's Registrar (KFin Technologies) and at its registered office in Hyderabad.
This is a routine regulatory compliance filing with no direct impact on stock price or operations. However, shareholders who have unclaimed dividends or outdated KYC records should act before the campaign ends on October 6, 2025 to avoid having shares or dividends transferred to the IEPF Authority.